ArticleJournal of the National Cancer Institute2022

Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.

Carlos A Garcia-Prieto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.